IL38378A - 3 -hydroxy-androstane-17 -carboxylic acid 17 -carboxaldehyde and 17 -carboxamide derivatives and their preparation - Google Patents
3 -hydroxy-androstane-17 -carboxylic acid 17 -carboxaldehyde and 17 -carboxamide derivatives and their preparationInfo
- Publication number
- IL38378A IL38378A IL7138378A IL3837871A IL38378A IL 38378 A IL38378 A IL 38378A IL 7138378 A IL7138378 A IL 7138378A IL 3837871 A IL3837871 A IL 3837871A IL 38378 A IL38378 A IL 38378A
- Authority
- IL
- Israel
- Prior art keywords
- androstane
- carboxaldehyde
- hydroxy
- preparation
- carboxylic acid
- Prior art date
Links
- KAYYIYDHRSEWHR-UHFFFAOYSA-N 3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthrene-17-carboxylic acid Chemical compound C1C(O)CCC2(C)C3CCC(C)(C(CC4)C(O)=O)C4C3CCC21 KAYYIYDHRSEWHR-UHFFFAOYSA-N 0.000 title 1
- 229940053202 antiepileptics carboxamide derivative Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB6007070 | 1970-12-17 | ||
| GB6006470A GB1380246A (en) | 1970-12-17 | 1970-12-17 | 3alpha-hydroxy-androstanes and esters thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL38378A0 IL38378A0 (en) | 1972-02-29 |
| IL38378A true IL38378A (en) | 1979-01-31 |
Family
ID=26267810
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL7138378A IL38378A (en) | 1970-12-17 | 1971-12-16 | 3 -hydroxy-androstane-17 -carboxylic acid 17 -carboxaldehyde and 17 -carboxamide derivatives and their preparation |
Country Status (7)
| Country | Link |
|---|---|
| AU (1) | AU473307B2 (enExample) |
| BE (1) | BE776791A (enExample) |
| DE (1) | DE2162595A1 (enExample) |
| FR (1) | FR2118123B1 (enExample) |
| GB (1) | GB1380246A (enExample) |
| IL (1) | IL38378A (enExample) |
| NL (1) | NL7117256A (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1434919A (en) * | 1972-06-15 | 1976-05-12 | Glaxo Lab Ltd | 3alpha-hydroxy androstanes |
| US5232917A (en) * | 1987-08-25 | 1993-08-03 | University Of Southern California | Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
| CA3152410A1 (en) | 2011-10-14 | 2013-04-18 | Sage Therapeutics, Inc. | 3,3-disubstituted 19-nor pregnane compounds, compositions, and uses thereof for the treatment of cns related disorders |
| CN113527400B (zh) | 2013-04-17 | 2024-06-28 | 萨奇治疗股份有限公司 | 19-去甲c3,3-二取代的c21-n-吡唑基类固醇及其使用方法 |
| WO2014169831A1 (en) | 2013-04-17 | 2014-10-23 | Sage Therapeutics, Inc. | 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof |
| RU2019126333A (ru) | 2013-04-17 | 2019-10-08 | Сейдж Терапьютикс, Инк. | 19-нор нейроактивные стероиды и способы их применения |
| US20160068563A1 (en) | 2013-04-17 | 2016-03-10 | Boyd L. Harrison | 19-nor neuroactive steroids and methods of use thereof |
| WO2015010054A2 (en) | 2013-07-19 | 2015-01-22 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| AU2014308621C1 (en) | 2013-08-23 | 2022-01-06 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| WO2015195962A1 (en) | 2014-06-18 | 2015-12-23 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| SMT202000414T1 (it) | 2014-10-16 | 2020-09-10 | Sage Therapeutics Inc | Composizioni e metodi per trattare disturbi del snc |
| MX2021004492A (es) | 2014-10-16 | 2022-12-05 | Sage Therapeutics Inc | Composiciones para el tratamiento de trastornos del snc. |
| ME03749B (me) | 2014-11-27 | 2021-04-20 | Sage Therapeutics Inc | KOMPOZICIJE I POSTUPCIZA LEČENJE POREMEĆAJA CNS-a |
| DK3250210T3 (da) | 2015-01-26 | 2021-03-08 | Sage Therapeutics Inc | Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser |
| JP6875996B2 (ja) | 2015-02-20 | 2021-05-26 | セージ セラピューティクス， インコーポレイテッド | 神経刺激性ステロイド、組成物、およびその使用 |
| CA3030420C (en) | 2016-07-11 | 2025-11-18 | Sage Therapeutics, Inc. | C7, C12 AND C16 SUBSTITUTED NEUROACTIVE STEROIDS AND ASSOCIATED METHODS OF USE |
| WO2018013613A1 (en) * | 2016-07-11 | 2018-01-18 | Sage Therapeutics, Inc. | C17, c20, and c21 substituted neuroactive steroids and their methods of use |
| US20220315621A1 (en) * | 2017-12-22 | 2022-10-06 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| IL275562B2 (en) * | 2017-12-22 | 2024-07-01 | Sage Therapeutics Inc | Compositions and methods for treating cns disorders |
| CN114206900A (zh) | 2019-05-31 | 2022-03-18 | 萨奇治疗股份有限公司 | 神经活性类固醇及其组合物 |
-
1970
- 1970-12-17 GB GB6006470A patent/GB1380246A/en not_active Expired
-
1971
- 1971-12-16 FR FR7145231A patent/FR2118123B1/fr not_active Expired
- 1971-12-16 NL NL7117256A patent/NL7117256A/xx unknown
- 1971-12-16 BE BE776791A patent/BE776791A/xx unknown
- 1971-12-16 IL IL7138378A patent/IL38378A/xx unknown
- 1971-12-16 DE DE19712162595 patent/DE2162595A1/de not_active Withdrawn
- 1971-12-16 AU AU36958/71A patent/AU473307B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| IL38378A0 (en) | 1972-02-29 |
| FR2118123B1 (enExample) | 1975-11-28 |
| AU473307B2 (en) | 1976-06-17 |
| DE2162595A1 (de) | 1972-07-06 |
| BE776791A (fr) | 1972-06-16 |
| FR2118123A1 (enExample) | 1972-07-28 |
| NL7117256A (enExample) | 1972-06-20 |
| AU3695871A (en) | 1973-06-21 |
| GB1380246A (en) | 1975-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY7500161A (en) | Phenoxy-hydroxypropylamines and their preparation | |
| HK86679A (en) | Dethiacephalosporanic acid derivatives and their preparation and use | |
| IL35916A0 (en) | Isoquinoline derivatives and their preparation | |
| PH10168A (en) | Barbituric acid derivatives and compositions comprising them | |
| IL35797A0 (en) | 3-propionyl-salicylic acid and its preparation | |
| GB1323371A (en) | Heterocyclized polydiynylenes and methods for their preparation | |
| AU465597B2 (en) | Azetidinane derivatives and their preparation | |
| PH10599A (en) | Fluorene-2-acetic acids and derivatives thereof | |
| IL36726A (en) | 15alpha-hydroxy-9-oxo-5-cis-13-transprostadienoic acid derivatives and process for their preparation | |
| IL37657A (en) | (4-sulfanilylphenyl)urea derivatives and their preparation | |
| IL37563A (en) | 8-cyano-5-octanolide and its preparation | |
| ZA705293B (en) | Ethylenediaminetetraacetic acid derivatives and their preparation | |
| IL36085A0 (en) | Benzocycloheptaisoquinoline derivatives and their preparation | |
| ZA716461B (en) | Pharmaceutical compositions | |
| IL37971A0 (en) | Thiocyanatobenzothiazoles and their preparation | |
| ZA711467B (en) | Thioxsanthene derivatives and their preparation | |
| IL32329A (en) | 6-isocyanatopenicillanic acid derivatives and their preparation | |
| IL36728A0 (en) | Substituted pyrrolylmethylamines and their preparation | |
| IL38281A0 (en) | Substituted butyronitriles and their preparation | |
| IL37008A (en) | Cyclophosphates and their preparation | |
| IL37932A0 (en) | Thiocyanatobenzothiazoles and their preparation | |
| IL37844A0 (en) | Derivatives of 1-amino-thioxanthen-9-one and their preparation | |
| CA842841A (en) | 6-diloweralkylamino-fluoran derivatives and their preparation and use | |
| PH11125A (en) | Sulphonyl-benzoic acid derivatives and pharmaceutical preparation thereof | |
| CA846847A (en) | Amino-benzoic acid derivatives and preparation thereof |